ATA111789A - Humaner monoklonaler antikörper und hybridom zur herstellung desselben - Google Patents

Humaner monoklonaler antikörper und hybridom zur herstellung desselben

Info

Publication number
ATA111789A
ATA111789A AT0111789A AT111789A ATA111789A AT A111789 A ATA111789 A AT A111789A AT 0111789 A AT0111789 A AT 0111789A AT 111789 A AT111789 A AT 111789A AT A111789 A ATA111789 A AT A111789A
Authority
AT
Austria
Prior art keywords
hybridome
production
monoclonal antibody
human monoclonal
human
Prior art date
Application number
AT0111789A
Other languages
English (en)
Other versions
AT397803B (de
Original Assignee
Sumitomo Chemical Co
Sumitomo Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sumitomo Chemical Co, Sumitomo Pharma filed Critical Sumitomo Chemical Co
Publication of ATA111789A publication Critical patent/ATA111789A/de
Application granted granted Critical
Publication of AT397803B publication Critical patent/AT397803B/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Gram-negative bacteria
    • C07K16/1214—Pseudomonadaceae (F)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
AT0111789A 1988-05-10 1989-05-10 Humaner monoklonaler antikörper und hybridom zur herstellung desselben AT397803B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP11447388 1988-05-10

Publications (2)

Publication Number Publication Date
ATA111789A true ATA111789A (de) 1993-11-15
AT397803B AT397803B (de) 1994-07-25

Family

ID=14638614

Family Applications (1)

Application Number Title Priority Date Filing Date
AT0111789A AT397803B (de) 1988-05-10 1989-05-10 Humaner monoklonaler antikörper und hybridom zur herstellung desselben

Country Status (10)

Country Link
US (1) US5252480A (de)
EP (1) EP0341684B1 (de)
JP (1) JP2645665B2 (de)
AT (1) AT397803B (de)
BE (1) BE1001964A4 (de)
CH (1) CH681012A5 (de)
DE (1) DE68920624T2 (de)
FR (1) FR2631239B1 (de)
GB (1) GB2218703B (de)
IT (1) IT1232273B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5521085A (en) * 1986-12-15 1996-05-28 Mitsui Toatsu Chemicals, Inc. Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes
EP0382031A3 (de) * 1989-02-10 1991-06-26 Miles Inc. Monoklonal-Antikörper in einer Zusammensetzung von Globulin aus Immunserum
JPH02283294A (ja) * 1989-04-24 1990-11-20 Sumitomo Chem Co Ltd ヒトモノクローナル抗体
JPH04211393A (ja) * 1990-02-08 1992-08-03 Sumitomo Pharmaceut Co Ltd ヒトモノクローナル抗体及びそれを有効成分とする緑膿菌感染症治療剤
GB9105292D0 (en) * 1991-03-13 1991-04-24 Sandoz Ltd Improvements in or relating to organic compounds
US5648660A (en) * 1996-01-05 1997-07-15 Sterling Diagnostic Imaging, Inc. Method and apparatus for reducing noise in a radiation capture device
US6197582B1 (en) 1998-03-18 2001-03-06 The Trustees Of Columbia University In The City Of New York Development of human monoclonal antibodies and uses thereof
CA2333147C (en) 1998-07-13 2012-02-07 Board Of Regents, The University Of Texas System Cancer treatment methods using antibodies to aminophospholipids
US7060802B1 (en) * 2000-09-18 2006-06-13 The Trustees Of Columbia University In The City Of New York Tumor-associated marker
AU2002213441B2 (en) * 2000-10-12 2006-10-26 Genentech, Inc. Reduced-viscosity concentrated protein formulations
US8703126B2 (en) 2000-10-12 2014-04-22 Genentech, Inc. Reduced-viscosity concentrated protein formulations
AU2003293543A1 (en) * 2002-12-13 2004-07-09 Abgenix, Inc. System and method for stabilizing antibodies with histidine
MXPA05010555A (es) † 2003-04-04 2006-03-09 Genentech Inc Formulaciones de proteina y anticuerpo de alta concentracion.
US20050158303A1 (en) * 2003-04-04 2005-07-21 Genentech, Inc. Methods of treating IgE-mediated disorders comprising the administration of high concentration anti-IgE antibody formulations
FR2859725B1 (fr) * 2003-09-16 2006-03-10 Neovacs Procede a haut rendement pour l'obtention d'anticorps humains neutralisant l'activite biologique d'une cytokine humaine
US20060051347A1 (en) 2004-09-09 2006-03-09 Winter Charles M Process for concentration of antibodies and therapeutic products thereof
AU2010221156A1 (en) * 2009-03-06 2011-09-22 Genentech, Inc. Antibody formulation

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0776240B2 (ja) * 1983-05-06 1995-08-16 ベロス グル−プ エンドトキシンコア−と反応性のモノクロ−ナル抗体
US5179018A (en) * 1983-10-14 1993-01-12 Centocor, Inc. Mamalian monoclonal antibodies against endotoxin of gram-negative bacteria
US4834975A (en) * 1984-05-25 1989-05-30 Genetics Corporation Human monoclonal antibodies to serotypic lipopolysaccharide determinants on gram-negative bacteria and their production
AU597877B2 (en) * 1984-12-26 1990-06-14 Teijin Limited Anti-pseudomonas aeruginosa human monoclonal antibody
AU584690B2 (en) * 1985-03-11 1989-06-01 Teijin Limited E87ag antigen of pseudomonas aeruginosa, monoclonal antibody against it, and hybridoma
US4918163A (en) * 1985-09-27 1990-04-17 Pfizer Inc. Monoclonal antibodies specific for lipid-A determinants of gram negative bacteria
US4777136A (en) * 1985-09-27 1988-10-11 The Regents Of The University Of California Monoclonal antibody reactive with Pseudomonas Aeruginosa
NZ218499A (en) * 1985-12-10 1990-04-26 Genetic Systems Corp Monoclonal antibodies against pseudomonas aeruginosa, pharmaceutical compositions and detection methods
JPS62215131A (ja) * 1986-03-13 1987-09-21 Kawasaki Heavy Ind Ltd 遠心クラツチ
EP0256713A3 (de) * 1986-08-06 1989-02-15 Merck & Co. Inc. Therapeutische, menschliche Antipseudomonas-Aeruginosa-Antikörper
WO1988008135A1 (en) * 1987-04-10 1988-10-20 Xoma Corporation Human monoclonal antibodies binding determinants of gram negative bacteria

Also Published As

Publication number Publication date
GB2218703B (en) 1992-10-28
AT397803B (de) 1994-07-25
JP2645665B2 (ja) 1997-08-25
IT1232273B (it) 1992-01-28
EP0341684A3 (en) 1990-01-17
GB8910395D0 (en) 1989-06-21
FR2631239A1 (fr) 1989-11-17
IT8967343A0 (it) 1989-05-09
US5252480A (en) 1993-10-12
BE1001964A4 (fr) 1990-04-24
DE68920624D1 (de) 1995-03-02
FR2631239B1 (fr) 1994-05-27
GB2218703A (en) 1989-11-22
JPH0284197A (ja) 1990-03-26
EP0341684B1 (de) 1995-01-18
CH681012A5 (de) 1992-12-31
DE68920624T2 (de) 1995-07-27
EP0341684A2 (de) 1989-11-15

Similar Documents

Publication Publication Date Title
DE69229254D1 (de) Verfahren zur Herstellung von menschlichen Lymphozyten und menschlichen Antikörpern; und so hergestellte Antikörper
ZA887987B (en) Monoclonal antibodies against human interleukin-4 and hybridomas producing the same
ATA111789A (de) Humaner monoklonaler antikörper und hybridom zur herstellung desselben
EP0692536A3 (de) Protein, das Interferon-Gamma Herstellung induziert und monoklonaler Antikörper dagegen
FI912016L (fi) In vitro -menetelmä antigeenispesifisten ihmisen monoklonaalisten vasta-aineiden valmistamiseksi
DE68912336D1 (de) Hydrophobe proteinmikroteilchen und verfahren zur herstellung.
ATA328286A (de) Zell-linien und verfahren zur herstellung von humanen monoklonalen antikörpern sowie kit und verfahren zur bestimmung der anwesenheit von p.aeruginosa
DE3889062D1 (de) Monoklonaler Antikörper gegen humanen BCDF.
DE68925350D1 (de) Supraleitendes oxidmaterial und verfahren zur herstellung
GB8702689D0 (en) Monoclonal human antibody compositions
DE68925366D1 (de) Konjugierte polypeptide und verfahren zur herstellung und verwendung
DE3788148D1 (de) Monoklonale Antikörper und deren Verwendung.
DE68906462D1 (de) Praeparat aus reiskleie und dessen verwendung.
DE68917457D1 (de) Deodorant und verfahren zur herstellung.
AU628288B2 (en) Cancer-related antigen-specific human immunoglobulins and human/human hybridomas having the ability to produce said human immunoglobulins
DE3583891D1 (de) Monoklonaler menschlicher anti-igg-koerper und verfahren zu seiner herstellung.
EP0285511A3 (en) Monoclonal antibodies and their uses
DE69129582D1 (de) Antikörper gegen menschlichen plasmin-alpha 2-plasmininhibitor-komplex, hybridoma und immunoassay
FI873606A7 (fi) Ihmisen glykoalbumiinin määrittämiseen käyttökelpoisia vasta-aineita.
DE69024871D1 (de) Monoklonaler Antikörper gegen menschliches BCDF und Immuntestverfahren unter dessen Verwendung
GB8901832D0 (en) Human monoclonal antibody and its production and use
DE68926899D1 (de) Hybride monoklonale Antikörper, ihre Herstellung und Verwendung
EP0229107A4 (de) Menschliche monoklonale antikörper gegen pseudomonas-aeruginosa-exotoxin.
DE3687542D1 (de) Monoklonaler antikoerper gegen humanes protein c.
DE3851541D1 (de) Propylen-äthylen-kopolymer-zusammensetzung und verfahren zur herstellung.

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee
REN Ceased due to non-payment of the annual fee